本页面由Tiger Trade Technology Pte. Ltd.提供服务

Gemini Therapeutics, Inc.

1.35
0.0000
成交量:- -
成交额:8.60万
市值:584.93万
市盈率:-0.13
高:1.35
开:1.35
低:1.35
收:1.35
52周最高:32.50
52周最低:1.35
股本:433.28万
流通股本:113.86万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-10.0468
每股收益(LYR):-17.8060
净资产收益率:-35.38%
总资产收益率:-19.49%
市净率:0.06
市盈率(LYR):-0.08

数据加载中...

2022/04/05

重要事件披露

8-K - Current report
2022/03/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/03/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/03/10

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/10

重要事件披露

8-K - Current report
2022/03/10

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/28

重要事件披露

8-K - Current report
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/03

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/01

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/14

重要事件披露

8-K - Current report
2022/01/10

重要事件披露

8-K - Current report
2021/11/15

重要事件披露

8-K - Current report
2021/11/15

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/11/12

重要事件披露

8-K - Current report
2021/10/15

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals